12,257
Total Claims
$1.7M
Drug Cost
1,032
Beneficiaries
$1,687
Cost/Patient
Peer Comparison vs. 18,720 Cardiology providers
+11%
Cost per patient vs peers
$1,687 vs $1,524 avg
Brand vs Generic
100% generic
Brand: 0 claims · $0
Generic: 10,070 claims · $182K
Top Prescribed Drugs
| Drug (Generic) | Claims | Cost |
|---|---|---|
| Sacubitril/Valsartan | 822 | $680K |
| Apixaban | 583 | $446K |
| Rivaroxaban | 306 | $221K |
| Empagliflozin | 79 | $54K |
| Ivabradine Hcl | 73 | $52K |
| Ranolazine | 323 | $40K |
| Ticagrelor | 39 | $23K |
| Metoprolol Succinate | 1,421 | $19K |
| Sitagliptin Phosphate | 23 | $16K |
| Clopidogrel Bisulfate | 994 | $13K |
| Dapagliflozin Propanediol | 14 | $12K |
| Valsartan | 528 | $11K |
| Nebivolol Hcl | 98 | $9,259 |
| Atorvastatin Calcium | 649 | $6,577 |
| Rosuvastatin Calcium | 301 | $4,454 |
Prescribing Profile
91
Unique Drugs
$1.4M
Patient Profile
70
Avg Age
56%
Female
1.72
Avg Risk Score
Explore More
Data from CMS Medicare Part D Prescriber Public Use File, 2023. Risk scores are statistical indicators, not allegations of wrongdoing.Methodology · About · Dispute this data